EPISODE · May 4, 2026 · 2 MIN
Cryoport's Q3 2025: Double-Digit Growth & New Milestones
from The Daily News Now! Business
Cryoports Q3 2025 earnings show robust growth, with Life Sciences Services revenue surging 16% and Commercial cell & gene therapy support soaring 36%. The Products segment also grew 15%, driven by stronger demand for cryogenic systems. Theyre now guiding full-year revenue at $170-174M. New initiatives include next-gen vapor shippers, IntegriCell services, and a global supply chain center in Paris. Despite a Q4 dip in guidance, analysts praise market resilience and growth investments. Cryoports new ISO certification and strategic partnerships solidify their position as a leader in regenerative medicine. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8bbb3d812570fe1f
NOW PLAYING
Cryoport's Q3 2025: Double-Digit Growth & New Milestones
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m